Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Octopus BiosafetySTU:OCR 2 12-1 Month Momentum % is 20.00% as of Sep. 21, 2026. GuruFocus rates STU:OCR with a GF Score™ of 2/100. The stock has 2 warning signs investors should review. Among 2,430 Hardware companies, Octopus Biosafety ranks worse than 94.57% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-21), Octopus Biosafety's 12-1 Month Momentum % is 20.00%.
The industry rank for Octopus Biosafety's 12-1 Month Momentum % or its related term are showing as below:
STU:OCR's 12-1 Month Momentum % is ranked worse than 94.57% of 2430
companies
in the Hardware industry
Industry Median: 1.78
vs STU:OCR: 20.00
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Octopus Biosafety 12-1 Month Momentum % Related Terms
STU:OCR vs DELL, ANET, SNDK: 12-1 Month Momentum % Comparison
For the Computer Hardware subindustry, Octopus Biosafety's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Octopus Biosafety 12-1 Month Momentum % vs Hardware Industry
For the Hardware industry and Technology sector, Octopus Biosafety's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Octopus Biosafety's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Octopus Biosafety (STU:OCR) has a 12-1 Month Momentum % of 20.00% as of Sep. 21, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Octopus Biosafety and its competitors. According to the industry distribution chart, Octopus Biosafety ranks #2298 out of 2430 companies in the Hardware industry, placing it in the top 94.6%.
Is Octopus Biosafety's 12-1 Month Momentum % too high?
Octopus Biosafety's current 12-1 Month Momentum % is 20.00%. The Hardware industry median 12-1 Month Momentum % is 1.78. Octopus Biosafety's value of 20.00% is 1023.6% above this industry median. Based on the distribution chart, Octopus Biosafety ranks #2298 out of 2430 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Octopus Biosafety has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's 12-1 Month Momentum % compare to DELL and ANET?
According to the Hardware industry distribution chart, Octopus Biosafety ranks #2298 out of 2430 companies for 12-1 Month Momentum %. This places Octopus Biosafety in the lower half of its industry. The industry median 12-1 Month Momentum % is 1.78. Octopus Biosafety's value of 20.00% is 1023.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Hardware company?
The median 12-1 Month Momentum % among Hardware companies is 1.78, based on 2,430 companies in the industry. Companies in the top quartile (top 25%) have a 12-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Octopus Biosafety's current 12-1 Month Momentum % of 20.00% is 1023.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Octopus Biosafety and its competitors. For the Hardware industry, the median 12-1 Month Momentum % is 1.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current 12-1 Month Momentum % is 20.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current 12-1 Month Momentum % of 20.00%. The current 12-1 Month Momentum % is 20.00% and 1023.6% above the Hardware industry median of 1.78. Octopus Biosafety's overall GF Score™ is 2/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current 12-1 Month Momentum % is 20.00% as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
2GF Score
Get the complete analysis for STU:OCR
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OCR has been successfully added to your 
